United Therapeutics (UTHR) EBT (QoQ) (2009 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) EBT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.09% |
| Mar 31, 2026 | -28.31% |
| Dec 31, 2025 | 1.37% |
| Sep 30, 2025 | 7.25% |
| Jun 30, 2025 | -3.57% |
| Mar 31, 2025 | 6.81% |
| Dec 31, 2024 | 2.03% |
| Sep 30, 2024 | 9.37% |
| Jun 30, 2024 | -10.86% |
| Mar 31, 2024 | 34.94% |
| Dec 31, 2023 | -16.03% |
| Sep 30, 2023 | 4.95% |
| Jun 30, 2023 | 14.83% |
| Mar 31, 2023 | 63.26% |
| Dec 31, 2022 | -42.78% |
| Sep 30, 2022 | 107.50% |
| Jun 30, 2022 | -51.21% |
| Mar 31, 2022 | 119.72% |
| Dec 31, 2021 | -31.26% |
| Sep 30, 2021 | -5.59% |